Pluri (PLUR) Net Margin (2011 - 2025)
Pluri (PLUR) posted quarterly Net Margin of 4546444.95% for Q4 2025, up 154729630.0% year-over-year from N/an in Q4 2024, and up 79.8% quarter-over-quarter from 2528587.03% in Q3 2025.
Pluri (PLUR) Net Margin (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Net Margin for 12 consecutive years, with 4546444.95% the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Margin rose 154729630.0% year-over-year to 4546444.95%; the TTM figure through Dec 2025 stood at 1268097.83% (down 35299051.0% YoY), while the FY2025 annual figure was 473988.55%, down 113206759.0% from the prior year.
- Net Margin climbed to 4546444.95% in Q4 2025 per PLUR's latest filing, from 2528587.03% in the prior quarter.
- Across five years, Net Margin topped out at 4546444.95% in Q4 2025 and bottomed at 423300.0% in Q4 2022.
- Historically, Net Margin has averaged 754844.85% across 4 years, with a median of 4671.43% in 2023.
- On a YoY basis, Net Margin climbed as much as 299447722 bps in 2024 and fell as far as 1726090 bps in 2024.
- Pluri's Net Margin stood at 423300.0% in 2022, then surged by 101 bps to 4671.43% in 2023, then jumped by 64102 bps to 2999148.65% in 2024, then soared by 52 bps to 4546444.95% in 2025.
- Business Quant data shows PLUR's Net Margin at 4546444.95% in Q4 2025, 2528587.03% in Q3 2025, and 1722.11% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.88 Bn | 132.03 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 86.62 Bn | 78.62 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 65.28 Bn | 60.10 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 61.39 Bn | 56.25 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 31.37 Bn | 28.06 Bn | 992.69 Mn | 12.74% |
| 7 | BioNTech SE | 28.76 Bn | 10.37 Bn | 668.28 Mn | -16.51% |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -3.12% |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 12.09% |
| 10 | Pluri | 15.74 Mn | 3.26 Mn | 86,000.00 | 4,546,444.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,546,444.95% |
| Sep 30, 2025 | 2,528,587.03% |
| Jun 30, 2025 | -1,722.11% |
| Mar 31, 2025 | -1,314.29% |
| Dec 31, 2024 | 2,999,148.65% |
| Sep 30, 2024 | 1,673,230.06% |
| Jun 30, 2024 | -6,512.50% |
| Mar 31, 2024 | -8,343.66% |
| Dec 31, 2023 | 4,671.43% |
| Sep 30, 2023 | 9,187.04% |
| Jun 30, 2023 | 5,441.44% |
| Mar 31, 2023 | 8,917.24% |
| Dec 31, 2022 | -423,300.00% |
| Sep 30, 2022 | -7,428.74% |
| Mar 31, 2022 | -4,333.76% |
| Dec 31, 2019 | -37,230.43% |
| Dec 31, 2018 | -18,220.00% |
| Sep 30, 2018 | -240,950.00% |
| Dec 31, 2017 | -17,466.00% |
| Dec 31, 2015 | -170.02% |